Apr 27, 2020
Harmony Biosciences Expands Patients At The Heart Grant Program And Reinforces Its Commitment To Newly Uninsured Patients
Mar 30, 2020
Harmony Biosciences Highlights Publication Of Narcolepsy Treatment Scientific Review In Sleep Medicine
Mar 25, 2020
Jazz Pharmaceuticals Announces FDA Acceptance of New Drug Application for JZP-258 for Cataplexy and Excessive Daytime Sleepiness Associated with Narcolepsy
Jan 22, 2020
Jazz Pharmaceuticals Submits New Drug Application for JZP-258 for Cataplexy and Excessive Daytime Sleepiness Associated with Narcolepsy
Sep 25, 2019
Jazz Pharmaceuticals Presents Positive JZP-258 Phase 3 Study Data at World Sleep 2019
Sep 20, 2019
Harmony Biosciences Announces Recipients of 2019 Patients at the Heart Grant in Recognition of World Narcolepsy Day
Sep 16, 2019
Harmony Biosciences To Present Clinical Data On WAKIX® (pitolisant) At Upcoming World Sleep 2019
Jun 24, 2019
FDA Grants Orphan Drug Designation to XW Laboratories' XWL-008 for the Treatment of Patients with Narcolepsy
Jun 04, 2019
Harmony Biosciences To Present New Data On Pitolisant In Patients With Narcolepsy At SLEEP 2019 Meeting
May 09, 2019
Jazz Pharmaceuticals Data to Showcase Ongoing Sleep Medicine Research at SLEEP 2019
Apr 29, 2019
Harmony Biosciences To Present Data On Pitolisant In Patients With Narcolepsy At 2019 American Academy Of Neurology Meeting
Mar 26, 2019
Jazz Pharmaceuticals Announces Positive Top-line Results from Phase 3 Study of JZP-258 in Adult Narcolepsy Patients with Cataplexy and Excessive Daytime Sleepiness
Dec 05, 2018
Harmony Biosciences Wins Four Industry Awards For Know Narcolepsy® Educational Campaign
Oct 29, 2018
Jazz Pharmaceuticals Announces FDA Approval of Xyrem® (sodium oxybate) for the Treatment of Cataplexy or Excessive Daytime Sleepiness in Pediatric Narcolepsy Patients
Oct 09, 2018
New Survey Identifies Need For Increased Education About And New Treatment Options For Narcolepsy
Sep 27, 2018
Data On Abuse Potential Of Pitolisant Presented At 2018 European Sleep (ESRS) Congress
Sep 24, 2018
Paragon Biosciences Congratulates Harmony Biosciences on the Grand Opening of Its Headquarters
Sep 05, 2018
Harmony Biosciences To Present Data On Its Investigational Product, Pitolisant, At Upcoming International Narcolepsy Symposium
Jul 25, 2018
Bioprojet and Endo Jointly Announce Agreement for Paladin Labs Inc. to Commercialize Pitolisant in Canada
Jun 27, 2018
Jazz Pharmaceuticals Announces FDA Acceptance of Supplemental New Drug Application for Xyrem® (sodium oxybate) to Treat Cataplexy and Excessive Daytime Sleepiness in Pediatric Narcolepsy Patients